Author

Christine Vestergaard Madsen

Observed name: Christine Vestergaard Madsen

Institution: Vejle Sygehus

Observed institution: Vejle Sygehus

OpenAlex ID: A5121593338

Rucaparib vs docetaxel (DTX) or second-generation androgen receptor pathway inhibitor (ARPI) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with BRCA mutations based on Eastern Cooperative Oncology Group performance status (ECOG PS) in TRITON3.

2026 · M. Neil Reaume, Karim Fizazi, et al. · Journal of Clinical Oncology

Impact of the Pre-radiotherapy Volume of the Urinary Bladder on its Filling Status During Hypo-fractionated Treatment for Prostate Cancer

2025 · DIRK RADES, STEFAN JANSSEN, et al. · Anticancer Research

Works count: 2

Citation count:

H-index:

I10-index: